ASAyesha Seth

Ayesha Seth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayesha Seth has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Six-Membered Concerted Mechanism for CO 2 Capture by Amines Studied under Charged Microdroplet Reaction Conditions

    by Taghi Sahraeian, Dmytro S. Kulyk, Ayesha Seth, Glib V. Baryshnikov, Abraham K. Badu-Tawiah

    Carbon dioxide (CO2) capture and storage represents an important technological challenge. A mechanistic understanding of interactions involved in the capture process is necessary not only for technological development but also for efficient conversion of captured CO2 into value-added materials. Herein, we present a novel contained secondary electrospray ionization platform for studying the interactions of gaseous amines and CO2 gas under microdroplet reaction conditions, which enables mass spectrometry (MS) characterization of CO2 capture products and intermediates in real time. We detected [2 M + CO2 + H]+ species, which corresponds to a six-membered intermediate. DFT calculations confirmed the high stability of the protonated six-membered ring intermediate. This finding provides a plausible concerted mechanism in the microdroplet environment that excludes the involvement of thermodynamically disfavored ionic species. The carbamic acid counterpart of the final product/salt was readily characterized by tandem MS. The carbamic acid/amine salt was also isolated and characterized by Fourier transform infrared spectroscopy. By virtue of the fact that headspace vapors of amines are sampled, we were able to establish a high-throughput platform that enabled the CO2 capture capacity of five different amines to be studied in under 2 min. The same device also enabled the absolute quantification of capture capacity.


  • Open Access

    A paper-based immunoassay with signal amplification for the sensitive detection of nucleocapsid protein toward the diagnosis of long COVID

    by Mônica Duarte da Silva, Ruth Speidel, Ayesha Seth, Hianka J. C. Carvalho, Maria A. Miglino, Abraham K. Badu-Tawiah

    Long COVID is characterized by persistent symptoms, including fatigue, cognitive impairment, and respiratory issues, affecting a considerable number of individuals post-infection.


  • Diagnosis On-Demand: Field Evaluation of Microfluidic Paper Device for the Detection of Asymptomatic Malaria

    by Ayesha Seth, Suji Lee, Girish Muralikrishnan, Edgar Garcia, James Odei, Abdul-Hakim Mutala, Kingsley Badu, Abraham K. Badu-Tawiah

    We report a proof-of-concept surveillance strategy that combines simplicity with modest cost to achieve high analytical performance for the detection of asymptomatic malaria infection. We developed a microfluidic paper-based analytical device (μPAD) that automates immunoassay using 30 μL of whole blood. A novel dendrimer-based signal transduction method was introduced to amplify the mass spectrometry (MS) signal. Our ability to detect an immunoassay signal with MS was achieved using cleavable ionic probes that were attached to monoclonal antibodies via dendrimer bioconjugation. The limit of detection of this MS-based immunoassay was determined to be 4.5 pM in serum for Plasmodium falciparum histidine-rich protein 2. The high stability of the ionic probes allowed storage of the paper device at room temperature, facilitating field sampling of whole blood from 266 asymptomatic volunteers in Ghana. The performance of the μPAD platform was compared with polymerase chain reaction (PCR), light microscopy, and rapid diagnostic test (RDT). Using PCR as the reference, we observed 96.5% sensitivity for our μPAD platform, as opposed to 43% for RDT and 16.9% for microscopy. Cohen's Kappa statistical analysis confirmed almost perfect agreement between μPAD and PCR (%agree = 81% in Kappa's categorical terms). False-negative rate in μPAD was calculated to be 3.5%. These results highlight the need for a more sensitive tool for asymptomatic malaria screening. Our method is highly sensitive yet deliverable, making sustainable implementation possible in underserved communities.


  • A 2D Microfluidic Paper-Based Analytical Device for Diagnosis of Canine Visceral Leishmaniasis via Mass Spectrometry-Based Immunoassay

    by Hianka J. C. de Carvalho, Ayesha Seth, Ruth Speidel, Ana L. Abreu-Silva, Hélida M. de Andrade, Maria A. Miglino, Abraham K. Badu-Tawiah

    This work presents the first indirect immunoassay performed on a paper-based microfluidic platform for the diagnosis of canine visceral leishmaniasis (CVL). The IgG antibody biomarker, which signifies the presence of this infectious disease, was captured with a recombinant K39 antigen and detected with secondary antibodies that were conjugated with cleavable ionic probes. The use of ionic probes enabled direct analysis of the assay results through an on-chip paper spray mass spectrometry (MS) technology. This MS-based immunoassay was developed to allow for early detection of CVL in asymptomatic dogs. The sensitivity required for such a diagnostic method was demonstrated through internal standard calibration in which sample dilution as low as 1/4000 was achieved. Aside from high sensitivity, the ionic probes are stable, which allowed the paper device to be stored at room temperature and under ambient conditions for 30 days without affecting the diagnostic outcome. Our method was used to analyze 20 clinical canine serum samples, where we detected a 2 orders of magnitude higher signal for CVL-positive samples compared to negative samples. MS signal derived from the 10 CVL-positive serum clinical samples showed a strong correlation with antibody titers determined by immunofluorescence assay. This correlation was confirmed through Pearson's statistical analysis. Overall, the high sensitivity and positive results from stability tests observed for our platform are expected to enable large-scale CVL screening in asymptomatic dogs in remote areas, especially when combined with portable mass spectrometers.